Back to top

stock-price-movement: Archive

Zacks Equity Research

HITACHI CHEMICL (HCHMY) Upgraded to Strong Buy: What Does It Mean for the Stock?

HITACHI CHEMICL (HCHMY) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

HCHMY

Zacks Equity Research

Evelo Biosciences, Inc. (EVLO) Upgraded to Strong Buy: What Does It Mean for the Stock?

Evelo Biosciences, Inc. (EVLO) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

EVLO

Zacks Equity Research

Editas (EDIT) Moves to Buy: Rationale Behind the Upgrade

Editas (EDIT) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

EDIT

Zacks Equity Research

Campbell (CPB) Moves to Buy: Rationale Behind the Upgrade

Campbell (CPB) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

CPB

Zacks Equity Research

Accelerate Diagnostics (AXDX) Moves to Strong Buy: Rationale Behind the Upgrade

Accelerate Diagnostics (AXDX) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

AXDX

Zacks Equity Research

Dollar General (DG) Upgraded to Buy: Here's What You Should Know

Dollar General (DG) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

DG

Zacks Equity Research

BRP Group, Inc. (BRP) Upgraded to Buy: Here's What You Should Know

BRP Group, Inc. (BRP) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

BRP

Zacks Equity Research

What Makes Bionano Genomics, Inc. (BNGO) a New Strong Buy Stock

Bionano Genomics, Inc. (BNGO) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

BNGO

Zacks Equity Research

Avinger (AVGR) Upgraded to Strong Buy: Here's Why

Avinger (AVGR) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

AVGR

Zacks Equity Research

AppFolio (APPF) Upgraded to Buy: What Does It Mean for the Stock?

AppFolio (APPF) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

APPF

Zacks Equity Research

All You Need to Know About Chesapeake Utilities (CPK) Rating Upgrade to Buy

Chesapeake Utilities (CPK) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

CPK

Zacks Equity Research

Cerus (CERS) Upgraded to Buy: What Does It Mean for the Stock?

Cerus (CERS) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

CERS

Zacks Equity Research

All You Need to Know About Baudax Bio, Inc. (BXRX) Rating Upgrade to Buy

Baudax Bio, Inc. (BXRX) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

BXRX

Zacks Equity Research

All You Need to Know About BIOMERIEUX (BMXMF) Rating Upgrade to Buy

BIOMERIEUX (BMXMF) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

BMXMF

Zacks Equity Research

Agnico (AEM) Upgraded to Strong Buy: What Does It Mean for the Stock?

Agnico (AEM) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

AEM

Zacks Equity Research

All You Need to Know About Celyad SA (CYAD) Rating Upgrade to Strong Buy

Celyad SA (CYAD) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

CYAD

Zacks Equity Research

Constellation Pharmaceuticals, Inc. (CNST) Upgraded to Buy: What Does It Mean for the Stock?

Constellation Pharmaceuticals, Inc. (CNST) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

CNST

Zacks Equity Research

Bluebird (BLUE) Upgraded to Buy: What Does It Mean for the Stock?

Bluebird (BLUE) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

BLUE

Zacks Equity Research

Applied Genetic Technologies (AGTC) Upgraded to Strong Buy: Here's What You Should Know

Applied Genetic Technologies (AGTC) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

AGTC

Zacks Equity Research

Aduro Biotech (ADRO) Upgraded to Buy: What Does It Mean for the Stock?

Aduro Biotech (ADRO) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

ADRO

Zacks Equity Research

All You Need to Know About CheckCap Ltd. (CHEK) Rating Upgrade to Buy

CheckCap Ltd. (CHEK) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

CHEK

Zacks Equity Research

All You Need to Know About Bellicum Pharmaceuticals (BLCM) Rating Upgrade to Strong Buy

Bellicum Pharmaceuticals (BLCM) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

BLCM

Zacks Equity Research

All You Need to Know About Alexco Resource (AXU) Rating Upgrade to Strong Buy

Alexco Resource (AXU) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

AXU

Zacks Equity Research

American Renal Associates (ARA) Upgraded to Buy: Here's What You Should Know

American Renal Associates (ARA) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

ARA

Zacks Equity Research

Audioeye, Inc. (AEYE) Upgraded to Strong Buy: Here's Why

Audioeye, Inc. (AEYE) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

AEYE